PRMT5 Promotes Symmetric Dimethylation of RNA Processing Proteins and Modulates Activated T Cell Alternative Splicing and Ca2+/NFAT Signaling. Academic Article uri icon


  • Protein arginine methyltransferase (PRMT) 5 is the type 2 methyltransferase catalyzing symmetric dimethylation of arginine. PRMT5 inhibition or deletion in CD4 Th cells reduces TCR engagement-induced IL-2 production and Th cell expansion and confers protection against experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis. However, the mechanisms by which PRMT5 modulates Th cell proliferation are still not completely understood, and neither are the methylation targets in T cells. In this manuscript, we uncover the role of PRMT5 on alternative splicing in activated mouse T cells and identify several targets of PRMT5 symmetric dimethylation involved in splicing. In addition, we find a possible link between PRMT5-mediated alternative splicing of transient receptor potential cation channel subfamily M member 4 (Trpm4) and TCR/NFAT signaling/IL-2 production. This understanding may guide development of drugs targeting these processes to benefit patients with T cell-mediated diseases.

published proceedings

  • Immunohorizons

altmetric score

  • 6.3

author list (cited authors)

  • Sengupta, S., West, K. O., Sanghvi, S., Laliotis, G., Agosto, L. M., Lynch, K. W., ... Guerau-de-Arellano, M.

citation count

  • 4

complete list of authors

  • Sengupta, Shouvonik||West, Kelsi O||Sanghvi, Shridhar||Laliotis, Georgios||Agosto, Laura M||Lynch, Kristen W||Tsichlis, Philip N||Singh, Harpreet||Patrick, Kristin L||Guerau-de-Arellano, Mireia

publication date

  • January 2021